Barinthus Biotherapeutics plc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2025.
  • Barinthus Biotherapeutics plc. Operating Lease, Payments for the quarter ending March 31, 2025 was $478K, a 38.2% increase year-over-year.
  • Barinthus Biotherapeutics plc. annual Operating Lease, Payments for 2024 was $1.79M, a 180% increase from 2023.
  • Barinthus Biotherapeutics plc. annual Operating Lease, Payments for 2023 was $639K, a 40.9% decline from 2022.
  • Barinthus Biotherapeutics plc. annual Operating Lease, Payments for 2022 was $1.08M, a 227% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $478K +$132K +38.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q1 2024 $346K +$126K +57.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q1 2023 $220K -$87K -28.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $307K +$226K +279% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-11
Q1 2021 $81K +$6K +8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $75K Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.